Lysophosphatidylcholine as a preferred carrier form of docosahexaenoic acid to the brain
- 683 Downloads
The metabolic fate of docosahexaenoic acid (DHA) was evaluated from its intake as a nutrient in triglycerides and phosphatidylcholines to its uptake by target tissues, especially the brain. Several approaches were used including the kinetics and tissue distribution of ingested 13C-labeled DHA, the incorporation of radiolabeled DHA injected as its nonesterified form compared to the fatty acid esterified in lysophosphatidylcholine (lysoPC), and the capacity of the two latter forms to cross a reconstituted blood-brain barrier (BBB) consisting of cocultures of brain-capillary endothelial cells and astrocytes. The results obtained allow us to raise the hypothesis that lysoPC may represent a preferred physiological carrier of DHA to the brain.
Index EntriesBlood-brain barrier fatty acid transport lysophospholipids Omega-3 fatty acids
Unable to display preview. Download preview PDF.
- Innis S. M. (1992) Plasma and red blood cell fatty acid values as indexes of essential fatty acid in the developing organs of infants fed with milk or formulas. J. Pediatr. 120, 578–586.Google Scholar
- Salem N. (1989) Omega-3 fatty acids: molecular and biochemical aspects, in New Protective Roles for Selected Nutrients. (Spiller G.A. and Scala J., eds.). John Wiley, New York, NY, pp. 109–228.Google Scholar
- Thiès F., Delachambre M. C., Bentejac M., Lagarde M., and Lecerf J. (1992) Unsaturated fatty acids esterified in 2-acyl,1-lysophosphatidylcholine bound to albumin are more efficiently taken up by the young rat brain than the unesterified form. J. Neurochem. 59, 1110–1116.PubMedCrossRefGoogle Scholar